시장보고서
상품코드
1090013

세계의 펩티드 치료제 시장 규모 : 투여 경로, 종류, 용도, 지역별 예측(2022-2028년)

Global Peptide Therapeutics Market Size study, By Route of Administration, By Type, By Application, and Regional Forecasts 2022-2028

발행일: | 리서치사: Bizwit Research & Consulting LLP | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

암이나 대사이상 발증률 상승, 신약 도입, 의료 활동에 대한 지출 증가가 세계 시장의 성장을 견인하는 현저한 요인입니다.

그러나 의약품 승인을 위한 엄격한 규제 부담과 의약품 개발의 고비용이 2022-2028년 예측기간 중 시장 성장을 저해할 전망입니다. 또한 연구개발 활동 상승과 기술 진보가 예측기간 중 시장 수요를 촉진할 것으로 예측됩니다.

세계의 펩티드 치료제(Peptide Therapeutics) 시장에 대해 조사 분석했으며, 시장 동향, 경쟁 상황, 부문별·지역별 시장 분석, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 펩티드 치료제 시장 정의와 범위

제3장 세계의 펩티드 치료제 시장 역학

  • 펩티드 치료제 시장 영향 분석(2020-2028년)

제4장 세계의 펩티드 치료제 시장 업계 분석

  • Porter's Five Forces 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천사항과 결론
  • 주요 투자 기회
  • 주요 성공 전략

제5장 위험 평가 : COVID-19의 영향

    • 업계에 대한 COVID-19의 전체적인 영향 평가
    • COVID-19 이전 및 COVID-19 이후 시장 시나리오

제6장 세계의 펩티드 치료제 시장 : 투여 경로별

  • 시장 현황
  • 시장 실적·잠재성 분석 : 투여 경로별
  • 시장 추정과 예측 : 투여 경로별(2018-2028년)
  • 하위 부문 분석
    • 비경구 경로
    • 경구 경로
    • 경폐
    • 점막
    • 기타

제7장 세계의 펩티드 치료제 시장 : 종류별

  • 시장 현황
  • 시장 실적·잠재성 분석 : 종류별
  • 시장 추정과 예측 : 종류별(2018-2028년)
  • 하위 부문 분석
    • 제네릭
    • 신약

제8장 세계의 펩티드 치료제 시장 : 용도별

  • 시장 현황
  • 시장 실적·잠재성 분석 : 용도별
  • 시장 추정과 예측 : 용도별(2018-2028년)
  • 하위 부문 분석
    • 심혈관질환
    • 중추신경계
    • 감염증
    • 호흡기질환
    • 기타 용도

제9장 세계의 펩티드 치료제 시장 : 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 지역

제10장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Eli Lilly and Company
    • Pfizer, Inc.
    • Amgen, Inc.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceuticals Industries Ltd.
    • Lonza Inc.
    • Sanofi
    • Bristol-Myers Squibb(BMS)
    • AstraZeneca PLC
    • Novartis AG

제11장 조사 과정

KSM 22.07.04

Global Peptide Therapeutics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Peptide therapeutics are a type of polypeptides or peptides that is primarily used to cure a wide range of diseases such as cancer, cardiovascular diseases, infections, respiratory disorders, and many others. The growing incidences of cancer and metabolic disorders, the introduction of novel drugs, and increasing spending on healthcare activities are some prominent factors excelling the global market growth. For instance, according to the National Cancer Institute, the number of cancer patients is expected to rise to 29.5 million cases by the year 2040 from 18.1 million cases in the year 2018. Consequentially, the growing cases of cancer are fueling the demand for the Peptide Therapeutics, which, in turn, augments the market growth across the globe. However, the imposition of stringent regulations for drug approval and the high cost of developing drugs impede the growth of the market over the forecast period of 2022-2028. Also, the rising research and development activities and technological advancements are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Peptide Therapeutics Market study include: Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growth of the biotechnology industry and rising focus on the introduction of novel drugs. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing investments in research and development activities, and the rising incidences of cancer, would create lucrative growth prospects for the Peptide Therapeutics Market across the Asia-Pacific region.

Major market players included in this report are:

  • Eli Lilly and Company
  • Pfizer, Inc.
  • Amgen, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Lonza Inc.
  • Sanofi
  • Bristol-Myers Squibb (BMS)
  • AstraZeneca PLC
  • Novartis AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

By Type:

  • Generic
  • Innovative

By Application:

  • Cancer
  • Cardiovascular Diseases
  • Central Nervous Systems
  • Infections
  • Respiratory Disorders
  • Other Applications

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2018, 2019, 2020
  • Base year - 2021
  • Forecast period - 2022 to 2028

Target Audience of the Global Peptide Therapeutics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Peptide Therapeutics Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Peptide Therapeutics Market, by Route of Administration, 2020-2028 (USD Million)
    • 1.2.3. Peptide Therapeutics Market, by Type, 2020-2028 (USD Million)
    • 1.2.4. Peptide Therapeutics Market, by Application, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Peptide Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Peptide Therapeutics Market Dynamics

  • 3.1. Peptide Therapeutics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing incidences of cancer and metabolic disorder
      • 3.1.1.2. Introduction of novel drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Imposition of stringent regulations for drug approval
      • 3.1.2.2. High cost of developing drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising research and development activities
      • 3.1.3.2. Technological advancements

Chapter 4. Global Peptide Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Peptide Therapeutics Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Peptide Therapeutics Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Peptide Therapeutics Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
  • 6.4. Peptide Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Parenteral Route
    • 6.4.2. Oral Route
    • 6.4.3. Pulmonary
    • 6.4.4. Mucosal
    • 6.4.5. Others

Chapter 7. Global Peptide Therapeutics Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Peptide Therapeutics Market by Type, Performance - Potential Analysis
  • 7.3. Global Peptide Therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
  • 7.4. Peptide Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Generic
    • 7.4.2. Innovative

Chapter 8. Global Peptide Therapeutics Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Peptide Therapeutics Market by Application, Performance - Potential Analysis
  • 8.3. Global Peptide Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
  • 8.4. Peptide Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Cancer
    • 8.4.2. Cardiovascular Diseases
    • 8.4.3. Central Nervous Systems
    • 8.4.4. Infections
    • 8.4.5. Respiratory Disorders
    • 8.4.6. Other Applications

Chapter 9. Global Peptide Therapeutics Market, Regional Analysis

  • 9.1. Peptide Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Peptide Therapeutics Market
    • 9.2.1. U.S. Peptide Therapeutics Market
      • 9.2.1.1. Route of Administration breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Application breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Peptide Therapeutics Market
  • 9.3. Europe Peptide Therapeutics Market Snapshot
    • 9.3.1. U.K. Peptide Therapeutics Market
    • 9.3.2. Germany Peptide Therapeutics Market
    • 9.3.3. France Peptide Therapeutics Market
    • 9.3.4. Spain Peptide Therapeutics Market
    • 9.3.5. Italy Peptide Therapeutics Market
    • 9.3.6. Rest of Europe Peptide Therapeutics Market
  • 9.4. Asia-Pacific Peptide Therapeutics Market Snapshot
    • 9.4.1. China Peptide Therapeutics Market
    • 9.4.2. India Peptide Therapeutics Market
    • 9.4.3. Japan Peptide Therapeutics Market
    • 9.4.4. Australia Peptide Therapeutics Market
    • 9.4.5. South Korea Peptide Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Peptide Therapeutics Market
  • 9.5. Latin America Peptide Therapeutics Market Snapshot
    • 9.5.1. Brazil Peptide Therapeutics Market
    • 9.5.2. Mexico Peptide Therapeutics Market
  • 9.6. Rest of The World Peptide Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Eli Lilly and Company
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Pfizer, Inc.
    • 10.2.3. Amgen, Inc.
    • 10.2.4. Takeda Pharmaceutical Company Limited
    • 10.2.5. Teva Pharmaceuticals Industries Ltd.
    • 10.2.6. Lonza Inc.
    • 10.2.7. Sanofi
    • 10.2.8. Bristol-Myers Squibb (BMS)
    • 10.2.9. AstraZeneca PLC
    • 10.2.10. Novartis AG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제